Boston Scientific, a manufacturer of medical devices, agreed to acquire Lumenis, a privately-held company that develops and commercializes energy-based medical solutions, from Baring Private Equity Asia, a private equity firm, for $1.07bn. Boston Scientific expects to complete the transaction in the second half 2021 and sees no material impact to its annual adjusted earnings from the deal. "The acquisition will expand our global footprint throughout Europe and Asia and accelerate the delivery of our robust stone management offerings to more urologists – ultimately serving more patients worldwide – while also improving our top-line growth and margins," Meghan Scanlon, Boston Scientific Senior Vice President and President of Urology and Pelvic Health.